Formidable Asset Management, LLC
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 1592613
CINCINNATI, OH
Position in ARCT
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$78,624
-$3,208 QoQ
Shares Held
11,700
+10.4% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#90
of 133 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Formidable Asset Management, LLC holds $7,832,997 across 10 Biotechnology names. ARCT ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
64,099 | $2,500,501 | |
| 2 | RPRX |
Royalty Pharma plc
|
32,010 | $1,794,800 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,518 | $1,747,496 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
7,828 | $680,644 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
847 | $528,138 | |
| 6 | TECH |
BIO-TECHNE Corp
|
5,017 | $354,451 | |
| 7 | ARCT |
Arcturus Therapeutics Holdings Inc.
This page
|
11,700 | $78,624 | |
| 8 | HELP |
Cybin Inc.
|
10,217 | $67,534 |
All Filings in ARCT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,624 | 11,700 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $81,832 | 10,600 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $61,913 | 10,100 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $189,829 | 10,300 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $191,247 | 14,700 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $155,673 | 14,700 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $308,854 | 18,200 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $424,743 | 18,300 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $457,780 | 18,800 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $604,483 | 17,900 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $490,291 | 15,550 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $384,527 | 15,050 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $428,766 | 14,950 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $358,351 | 14,950 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $268,816 | 15,850 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $231,933 | 15,650 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $235,313 | 14,950 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $378,788 | 14,050 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $479,279 | 12,950 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $633,085 | 13,250 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $417,078 | 12,325 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $283,937 | 6,875 | Shares | Sole | 2021-05-12 | |
| 2020-06-30 | $227,436 | 4,866 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||